Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Longevity of seropositivity and neutralizing titers among SARS-CoV-2 infected individuals after 4 months from baseline: a population-based study in the province of Trento

View ORCID ProfilePaola Stefanelli, Antonino Bella, Giorgio Fedele, Stefano Fiore, Serena Pancheri, Eleonora Benedetti, Concetta Fabiani, Pasqualina Leone, Paola Vacca, Ilaria Schiavoni, Arianna Neri, Anna Carannante, Maurizio Simmaco, Iolanda Santino, Maria Grazia Zuccali, Giancarlo Bizzarri, Rosa Magnoni, Pier Paolo Benetollo, Silvio Brusaferro, Giovanni Rezza, Antonio Ferro
doi: https://doi.org/10.1101/2020.11.11.20229062
Paola Stefanelli
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paola Stefanelli
  • For correspondence: paola.stefanelli@iss.it
Antonino Bella
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giorgio Fedele
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Fiore
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serena Pancheri
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleonora Benedetti
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Concetta Fabiani
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pasqualina Leone
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Vacca
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilaria Schiavoni
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arianna Neri
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Carannante
aDepartment Infectious Diseases, Istituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurizio Simmaco
cHospital Direction and Clinical Departments, Sant’Andrea University Hospital, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iolanda Santino
cHospital Direction and Clinical Departments, Sant’Andrea University Hospital, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Grazia Zuccali
bAPSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giancarlo Bizzarri
bAPSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Magnoni
bAPSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pier Paolo Benetollo
bAPSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvio Brusaferro
dIstituto Superiore di Sanità, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Rezza
eHealth Prevention Directorate, Ministry of Health, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Ferro
bAPSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

Background There are conflicting results about the duration of antibodies induced by SARS-CoV-2, but several studies show a rapid decay in a few months after infection. To evaluate antibody decline, we re-evaluated the presence of anti-SARS-CoV-2 antibodies among individuals found seropositive in a first population survey conducted 4 months before.

Methods All individuals above ten years of age resident in 5 municipalities of the Autonomous Province of Trento, northern Italy, who resulted IgG positive for anti-SARS-CoV-2 nucleocapsid (NC) antibodies in a serosurvey conducted on May 2020 were retested after 4 months. Anti-SARS-CoV-2 antibodies were detected using the Abbott SARS-CoV-2 IgG assay (Abbott Diagnostics, USA) detecting anti-NC antibodies. Samples that gave a negative result were re-tested using the same test plus Liaison SARS-CoV-2 IgG assay (DiaSorin, Italy) to assess anti-spike (S) S1/S2 IgG antibodies. Seroprevalence was calculated as the proportion of positive people on the total number of tested. A neutralizing assay was performed on a subgroup of formerly positives sera using fifty-percent tissue culture infective dose (TCID50) as endpoint dilution to produce a cytopathic effect in 50% of inoculated Vero E6 cells culture. In all the analyses a p value < 0.05 were considered statistically significant. Statistical analysis was performed by STATA version 16.1 (STATA Corp., College Station, Texas, USA).

Findings Overall, 1159 out of 1402 initially anti-NC seropositive participants were enrolled in the study. Of them, 480 (41.1%) became seronegative for anti-NC IgG antibodies. When 479 negative sera were tested for anti-S IgG, 373 samples (77.9%) resulted positives. A functional neutralization assay was performed on 106 sera showing high concordance with anti-S antibodies positivity.

Interpretation A decline of anti-NC IgG values was recorded 4 months after the first evaluation. Worth of note, a high proportion of anti-NC seronegative individuals were positive for anti-spike IgG antibodies, which appear to persist longer and to better correlate with neutralization activity.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

APSS sustained the expenses for the IgG assays on collected sera.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval Informed consensus for blood collection was obtained from all the participants. The study was approved by the Ethical Committee of the ISS (Prot. PRE BIO CE n.15997, 04.05.2020).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

NA

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 16, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Longevity of seropositivity and neutralizing titers among SARS-CoV-2 infected individuals after 4 months from baseline: a population-based study in the province of Trento
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Longevity of seropositivity and neutralizing titers among SARS-CoV-2 infected individuals after 4 months from baseline: a population-based study in the province of Trento
Paola Stefanelli, Antonino Bella, Giorgio Fedele, Stefano Fiore, Serena Pancheri, Eleonora Benedetti, Concetta Fabiani, Pasqualina Leone, Paola Vacca, Ilaria Schiavoni, Arianna Neri, Anna Carannante, Maurizio Simmaco, Iolanda Santino, Maria Grazia Zuccali, Giancarlo Bizzarri, Rosa Magnoni, Pier Paolo Benetollo, Silvio Brusaferro, Giovanni Rezza, Antonio Ferro
medRxiv 2020.11.11.20229062; doi: https://doi.org/10.1101/2020.11.11.20229062
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Longevity of seropositivity and neutralizing titers among SARS-CoV-2 infected individuals after 4 months from baseline: a population-based study in the province of Trento
Paola Stefanelli, Antonino Bella, Giorgio Fedele, Stefano Fiore, Serena Pancheri, Eleonora Benedetti, Concetta Fabiani, Pasqualina Leone, Paola Vacca, Ilaria Schiavoni, Arianna Neri, Anna Carannante, Maurizio Simmaco, Iolanda Santino, Maria Grazia Zuccali, Giancarlo Bizzarri, Rosa Magnoni, Pier Paolo Benetollo, Silvio Brusaferro, Giovanni Rezza, Antonio Ferro
medRxiv 2020.11.11.20229062; doi: https://doi.org/10.1101/2020.11.11.20229062

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)